Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anatolii N. Rogoza"'
Autor:
Irina E. Chazova, Sergei P. Golitsyn, Juliya V. Zhernakova, Ekaterina A. Zheleznova, Ekaterina S. Kropacheva, Nikolai Iu. Mironov, Marina V. Kostiukevich, Lada Iu. Laiovich, Madina D. Utsumueva, Iuliia A. Iuricheva, Alexander Yu. Litvin, Evgeniia M. Elfimova, Anatolii N. Rogoza, Elizaveta P. Panchenko
Publikováno v:
Системные гипертензии, Vol 18, Iss 3, Pp 105-128 (2021)
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF d
Externí odkaz:
https://doaj.org/article/a62932e2890b4be5b090cec8bd168e61
Autor:
Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galyavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publikováno v:
Системные гипертензии, Vol 18, Iss 1, Pp 50-62 (2021)
Aim. To assess the efficacy and safety of Vamloset (amlodipine/valsartan 5/80, 5/160, 10/160 mg) and Co-Vamloset (amlodipine/valsartan/hydrochlorothiazide 10/160/12.5, 10/160/25 mg) in achieving the target levels of blood pressure (BP) in patients wi
Externí odkaz:
https://doaj.org/article/60c64f07123347219ac33339c22c4a57
Autor:
Marina V. Andreevskaia, Ekaterina A. Zheleznova, Juliya V. Zhernakova, Irina E. Chazova, Merab A. Shariia, Nataliia V. Blinova, Alsu R. Zairova, Marina O. Azimova, Anatolii N. Rogoza, Marina A. Saidova
Publikováno v:
Системные гипертензии, Vol 17, Iss 4, Pp 55-62 (2021)
Overweight is closely associated with development of cardiovascular disorders. Currently, the terms metabolically healthy abdominal obesity (MHAO) and metabolically unhealthy obesity, i.e., metabolic syndrome (MS) are stated. Comparison target organs
Externí odkaz:
https://doaj.org/article/cd428938c63141288bc0fd4ca6d0bb72
Autor:
Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publikováno v:
Системные гипертензии, Vol 17, Iss 3, Pp 59-70 (2020)
Aim.Assessment of Vamloset and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-a,
Externí odkaz:
https://doaj.org/article/749491d786994f6493162a7284467d61
Publikováno v:
Системные гипертензии, Vol 16, Iss 2, Pp 47-53 (2019)
Aim. To study the relationship of orthostatic hypotensive reactions (OHR), detected using active (AOT) and passive orthostatic tests (POT) with the state of cognitive functions in patients with arterial hypertension (AH) in older age groups. Material
Externí odkaz:
https://doaj.org/article/be571f9fcf714b12b503ae7ee43b8f03
Publikováno v:
Системные гипертензии, Vol 16, Iss 2, Pp 47-53 (2019)
Aim. To study the relationship of orthostatic hypotensive reactions (OHR), detected using active (AOT) and passive orthostatic tests (POT) with the state of cognitive functions in patients with arterial hypertension (AH) in older age groups. Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f57a6bbfb2ea34d13fd3faf3a594f7e
https://doi.org/10.26442/2075082x.2019.2.190357
https://doi.org/10.26442/2075082x.2019.2.190357